标题
State of the Art: Response Assessment in Lung Cancer in the Era of Genomic Medicine
作者
关键词
-
出版物
RADIOLOGY
Volume 271, Issue 1, Pages 6-27
出版商
Radiological Society of North America (RSNA)
发表日期
2014-03-25
DOI
10.1148/radiol.14122524
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with ALK-positive non-small cell lung cancer (NSCLC).
- (2017) D. R. Camidge et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI’s Lung Cancer Mutation Consortium (LCMC).
- (2017) M. G. Kris et al. JOURNAL OF CLINICAL ONCOLOGY
- Measurement of Tumor Volumes Improves RECIST-Based Response Assessments in Advanced Lung Cancer
- (2014) P. David Mozley et al. Translational Oncology
- Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECIST
- (2012) Mizuki Nishino et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
- (2012) Marcin Imielinski et al. CELL
- Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
- (2012) Thomas J. Lynch et al. JOURNAL OF CLINICAL ONCOLOGY
- ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
- (2012) Kristin Bergethon et al. JOURNAL OF CLINICAL ONCOLOGY
- ROS1 Rearrangements in Lung Cancer: A New Genomic Subset of Lung Adenocarcinoma
- (2012) Pasi A. Jänne et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-FDG PET as a Surrogate Biomarker in Non-Small Cell Lung Cancer Treated with Erlotinib: Newly Identified Lesions Are More Informative Than Standardized Uptake Value
- (2012) T. Bengtsson et al. JOURNAL OF NUCLEAR MEDICINE
- Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
- (2012) D Ross Camidge et al. LANCET ONCOLOGY
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors
- (2012) Mizuki Nishino et al. LUNG CANCER
- Clinical application of pharmacokinetic analysis as a biomarker of solitary pulmonary nodules: Dynamic contrast-enhanced MR imaging
- (2012) Hatsuho Mamata et al. MAGNETIC RESONANCE IN MEDICINE
- Tumor Heterogeneity and Personalized Medicine
- (2012) Dan L. Longo NEW ENGLAND JOURNAL OF MEDICINE
- Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab
- (2012) Mizuki Nishinoa et al. CANCER IMAGING
- Imaging of Lung Cancer in the Era of Molecular Medicine
- (2011) Mizuki Nishino et al. ACADEMIC RADIOLOGY
- Prognostic Value of the Quantitative Metabolic Volumetric Measurement on 18F-FDG PET/CT in Stage IV Nonsurgical Small-cell Lung Cancer
- (2011) Shengri Liao et al. ACADEMIC RADIOLOGY
- Reproducibility of Perfusion Parameters Obtained From Perfusion CT in Lung Tumors
- (2011) Chaan S. Ng et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Diffusion-Weighted MRI Versus 18F-FDG PET/CT: Performance as Predictors of Tumor Treatment Response and Patient Survival in Patients With Non–Small Cell Lung Cancer Receiving Chemoradiotherapy
- (2011) Yoshiharu Ohno et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer
- (2011) A A Memon et al. BRITISH JOURNAL OF CANCER
- Absolute Quantification of [11C]docetaxel Kinetics in Lung Cancer Patients Using Positron Emission Tomography
- (2011) A. A. M. van der Veldt et al. CLINICAL CANCER RESEARCH
- Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung
- (2011) R. Takahashi et al. CLINICAL CANCER RESEARCH
- Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non-Small Cell Lung Cancer Treated with Erlotinib
- (2011) L. Mileshkin et al. CLINICAL CANCER RESEARCH
- Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Sorafenib
- (2011) R. J. Kelly et al. CLINICAL CANCER RESEARCH
- A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12weeks
- (2011) M.E.R. O’Brien et al. EUROPEAN JOURNAL OF CANCER
- Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer
- (2011) Wei Huang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer
- (2011) Shengri Liao et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Intraobserver and interobserver agreement of volume perfusion CT (VPCT) measurements in patients with lung lesions
- (2011) Alexander W. Sauter et al. EUROPEAN JOURNAL OF RADIOLOGY
- Early Prediction of Nonprogression in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib By Using [18F]Fluorodeoxyglucose and [18F]Fluorothymidine Positron Emission Tomography
- (2011) Thomas Zander et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy
- (2011) Vicki Leigh Keedy et al. JOURNAL OF CLINICAL ONCOLOGY
- Variations in PET/CT Methodology for Oncologic Imaging at U.S. Academic Medical Centers: An Imaging Response Assessment Team Survey
- (2011) M. M. Graham et al. JOURNAL OF NUCLEAR MEDICINE
- Phase II Trial of Dasatinib for Patients with Acquired Resistance to Treatment with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Erlotinib or Gefitinib
- (2011) Melissa L. Johnson et al. Journal of Thoracic Oncology
- Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer
- (2011) Margaret M. Kozak et al. Journal of Thoracic Oncology
- Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
- (2011) Caicun Zhou et al. LANCET ONCOLOGY
- Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
- (2011) R. H. Mak et al. ONCOLOGIST
- Whole-Tumor Perfusion CT in Patients with Advanced Lung Adenocarcinoma Treated with Conventional and Antiangiogenetic Chemotherapy: Initial Experience
- (2011) Francesco Fraioli et al. RADIOLOGY
- Non–Small Cell Lung Cancer: Detection of Early Response to Chemotherapy by Using Contrast-enhanced Dynamic and Diffusion-weighted MR Imaging
- (2011) Hidetake Yabuuchi et al. RADIOLOGY
- The BATTLE Trial: Personalizing Therapy for Lung Cancer
- (2011) Edward S. Kim et al. Cancer Discovery
- CT Tumor Volume Measurement in Advanced Non-small-cell Lung Cancer
- (2010) Mizuki Nishino et al. ACADEMIC RADIOLOGY
- New Response Evaluation Criteria in Solid Tumors (RECIST) Guidelines for Advanced Non–Small Cell Lung Cancer: Comparison With Original RECIST and Impact on Assessment of Tumor Response to Targeted Therapy
- (2010) Mizuki Nishino et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Assessment of Therapy Response in Lung Cancer With18F-α-Methyl Tyrosine PET
- (2010) Kyoichi Kaira et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Revised RECIST Guideline Version 1.1: What Oncologists Want to Know and What Radiologists Need to Know
- (2010) Mizuki Nishino et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging
- (2010) A.-M. C. Dingemans et al. ANNALS OF ONCOLOGY
- A Pilot Study of Volume Measurement as a Method of Tumor Response Evaluation to Aid Biomarker Development
- (2010) B. Zhao et al. CLINICAL CANCER RESEARCH
- Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients
- (2010) Astrid A. M. van der Veldt et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
- (2010) Joline S. W. Lind et al. EUROPEAN RADIOLOGY
- Tumor Volume Is a Prognostic Factor in Non–Small-Cell Lung Cancer Treated With Chemoradiotherapy
- (2010) Brian M. Alexander et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI
- (2010) A. J. de Langen et al. JOURNAL OF NUCLEAR MEDICINE
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of Non–Small Cell Lung Cancer Perfusion: Pathologic-CT Correlation in 15 Patients
- (2010) Nunzia Tacelli et al. RADIOLOGY
- Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer: Perfusion CT Evaluation of Chemotherapy and Radiation Therapy
- (2009) Jianwei Wang et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- TheEML4-ALKfusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-typeEGFRandKRAS
- (2009) Daisy Wing-Sze Wong et al. CANCER
- Positron Emission Tomography (PET) Imaging with [11C]-Labeled Erlotinib: A Micro-PET Study on Mice with Lung Tumor Xenografts
- (2009) A. A. Memon et al. CANCER RESEARCH
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Living With Imperfection
- (2009) Tony S.K. Mok JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Interobserver Reproducibility in Quantitative 18F-FDG PET and CT Measurements of Tumor Response to Therapy
- (2009) H. A. Jacene et al. JOURNAL OF NUCLEAR MEDICINE
- Role of 18F-FDG PET in Assessment of Response in Non-Small Cell Lung Cancer
- (2009) R. J. Hicks JOURNAL OF NUCLEAR MEDICINE
- Personalized Medicine and Inhibition ofEGFRSignaling in Lung Cancer
- (2009) Adi F. Gazdar NEW ENGLAND JOURNAL OF MEDICINE
- Preoperative Staging of Lung Cancer with Combined PET–CT
- (2009) Barbara Fischer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Noncalcified Lung Nodules: Volumetric Assessment with Thoracic CT
- (2009) Marios A. Gavrielides et al. RADIOLOGY
- Evaluating Variability in Tumor Measurements from Same-day Repeat CT Scans of Patients with Non–Small Cell Lung Cancer
- (2009) Binsheng Zhao et al. RADIOLOGY
- Can Malignant and Benign Pulmonary Nodules Be Differentiated with Diffusion-Weighted MRI?
- (2008) Shiro Satoh et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
- (2008) J. P. Koivunen et al. CLINICAL CANCER RESEARCH
- [18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung
- (2008) H.-J. Sohn et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations
- (2008) Lecia V. Sequist et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer
- (2008) Simon J. Crabb et al. JOURNAL OF CLINICAL ONCOLOGY
- Reproducibility of Standardized Uptake Value Measurements Determined by 18F-FDG PET in Malignant Tumors
- (2008) C. Nahmias et al. JOURNAL OF NUCLEAR MEDICINE
- Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography
- (2008) Takeshi Mori et al. Journal of Thoracic Oncology
- Tumor Cavitation During Therapy with Antiangiogenesis Agents in Patients with Lung Cancer
- (2008) Edith M. Marom et al. Journal of Thoracic Oncology
- EGFR gene copy number in adenocarcinoma of the lung by FISH analysis: Investigation of significantly related factors on CT, FDG-PET, and histopathology
- (2008) Eun-Ah Park et al. LUNG CANCER
- Somatic mutations affect key pathways in lung adenocarcinoma
- (2008) Li Ding et al. NATURE
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Solitary Pulmonary Nodules: Meta-analytic Comparison of Cross-sectional Imaging Modalities for Diagnosis of Malignancy
- (2008) Paul Cronin et al. RADIOLOGY
- Tumor Volume Combined With Number of Positive Lymph Node Stations Is a More Important Prognostic Factor Than TNM Stage for Survival of Non–Small-Cell Lung Cancer Patients Treated With (Chemo)radiotherapy
- (2007) Cary Dehing-Oberije et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now